Having trouble viewing this email? View in your browser.
ESCMID Logo

27 March 2018
WEEKLY NEWS

Dear colleagues,

ESCMID members may be interested to access the information on REVIVE, a hub developed by the Global Antibiotic Research & Development Partnership (GARDP) aimed at bringing together researchers and drug developers. The group also organizes websymposiums on topics in connection with the development of antibacterial drugs.

Your ESCMID communications editors

ESCMID Executive Office
Aeschenvorstadt 55
4051 Basel
Switzerland
Phone +41 61 508 0150
info@escmid.org
Follow ESCMID
Visit us on mastodon Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions .